THG PLC (LSE:THG) has forecast adjusted EBITDA for fiscal year 2022 in line with current market expectations as it embarks on another revamp of the business, this time looking at non-core trading activities.
In a trading statement, the company reiterated its medium-term adjusted EBITDA margin guidance of >9.0% as it reported record sales of £2.25bn for the year, up 4.1%, with +9.4% growth in THG Beauty and THG Nutrition.
A reorganisation of the business has resulted in around £100mln of cost savings in the financial year and a further £30mln of savings are targeted for delivery during the coming fiscal year.
Following this divisional review, THG has embarked on another revamp, this time looking at trading outside of the three core divisions it intends to focus on - THG Beauty, THG Nutrition and THG Ingenuity.
These three divisions are expected to deliver adjusted EBITDA on a continuing basis of c. £100mln in the fiscal year 2022, reflecting the removal of around £20mln of losses from discontinued revenues.
“While the decision to discontinue certain trading activities has occurred already, the full outcome of the review will complete in H1 2023,” THG said.
“The combined impact of the lower full-year sales outturn, the dilutive impact of loss-making categories under review, alongside the timing of impending new Ingenuity contracts results in an expected adjusted EBITDA outturn range of £70mln to £80mln for FY 2022,” the company said.
"With the completion of the divisional reorganisation, and around £100mln of annual efficiency savings already delivered, the group enters 2023 with strong momentum to achieve substantial margin expansion,” Matthew Moulding, CEO commented.